Cargando…
Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials
OBJECTIVES: Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to assess the efficacy and safety of adding clopidogrel to aspirin on stroke prevention in high vascular risk patients, and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128803/ https://www.ncbi.nlm.nih.gov/pubmed/25110930 http://dx.doi.org/10.1371/journal.pone.0104402 |
_version_ | 1782330176219119616 |
---|---|
author | Chen, Shuying Shen, Qingyu Tang, Yamei He, Lei Li, Yi Li, Hui Li, Mei Peng, Ying |
author_facet | Chen, Shuying Shen, Qingyu Tang, Yamei He, Lei Li, Yi Li, Hui Li, Mei Peng, Ying |
author_sort | Chen, Shuying |
collection | PubMed |
description | OBJECTIVES: Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to assess the efficacy and safety of adding clopidogrel to aspirin on stroke prevention in high vascular risk patients, and to provide evidence for a suitable duration of dual antiplatelet therapy. METHODS: We searched PubMed, EMBase, OVID and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of clopidogrel plus aspirin versus aspirin alone in high vascular risk patients. Comparisons of stroke and hemorrhagic complications between treatment groups were expressed by the pooled Relative Risks (RRs) with 95% Confidence Intervals (CIs). RESULTS: Fifteen trials with a total of 97692 intention-to-treat participants were included with duration of follow-up ranging from 7 days to 3.6 years. Dual antiplatelet therapy reduced all stroke by 21% (RR: 0.79, 95% CI: 0.73–0.85) with no evidence of heterogeneity across the trials (P = 0.27, I (2) = 17%).The effects were consistent between short-term subgroup (≤1 month, RR: 0.76, 95% CI: 0.67–0.85) and long-term subgroup (≥3 months, RR: 0.81, 95% CI: 0.73–0.89). The risk of major bleeding was not significantly increased by dual antiplatelet therapy in short-term subgroup (RR: 1.11, 95% CI: 0.91–1.36), while significantly increased in long-term subgroup (RR: 1.52, 95% CI: 1.36–1.69). Long-term dual antiplatelet therapy substantially increased the risk of intracranial bleeding (RR: 1.76, 95% CI: 1.22–2.54). CONCLUSIONS: This meta-analysis demonstrates that short-term combination of clopidogrel and aspirin is effective and safe for stroke prevention in high vascular risk patients. Long-term combination therapy substantially increases the risk of major bleeding and intracranial bleeding. |
format | Online Article Text |
id | pubmed-4128803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41288032014-08-12 Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials Chen, Shuying Shen, Qingyu Tang, Yamei He, Lei Li, Yi Li, Hui Li, Mei Peng, Ying PLoS One Research Article OBJECTIVES: Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to assess the efficacy and safety of adding clopidogrel to aspirin on stroke prevention in high vascular risk patients, and to provide evidence for a suitable duration of dual antiplatelet therapy. METHODS: We searched PubMed, EMBase, OVID and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of clopidogrel plus aspirin versus aspirin alone in high vascular risk patients. Comparisons of stroke and hemorrhagic complications between treatment groups were expressed by the pooled Relative Risks (RRs) with 95% Confidence Intervals (CIs). RESULTS: Fifteen trials with a total of 97692 intention-to-treat participants were included with duration of follow-up ranging from 7 days to 3.6 years. Dual antiplatelet therapy reduced all stroke by 21% (RR: 0.79, 95% CI: 0.73–0.85) with no evidence of heterogeneity across the trials (P = 0.27, I (2) = 17%).The effects were consistent between short-term subgroup (≤1 month, RR: 0.76, 95% CI: 0.67–0.85) and long-term subgroup (≥3 months, RR: 0.81, 95% CI: 0.73–0.89). The risk of major bleeding was not significantly increased by dual antiplatelet therapy in short-term subgroup (RR: 1.11, 95% CI: 0.91–1.36), while significantly increased in long-term subgroup (RR: 1.52, 95% CI: 1.36–1.69). Long-term dual antiplatelet therapy substantially increased the risk of intracranial bleeding (RR: 1.76, 95% CI: 1.22–2.54). CONCLUSIONS: This meta-analysis demonstrates that short-term combination of clopidogrel and aspirin is effective and safe for stroke prevention in high vascular risk patients. Long-term combination therapy substantially increases the risk of major bleeding and intracranial bleeding. Public Library of Science 2014-08-11 /pmc/articles/PMC4128803/ /pubmed/25110930 http://dx.doi.org/10.1371/journal.pone.0104402 Text en © 2014 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Chen, Shuying Shen, Qingyu Tang, Yamei He, Lei Li, Yi Li, Hui Li, Mei Peng, Ying Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials |
title | Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials |
title_full | Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials |
title_fullStr | Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials |
title_short | Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials |
title_sort | efficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128803/ https://www.ncbi.nlm.nih.gov/pubmed/25110930 http://dx.doi.org/10.1371/journal.pone.0104402 |
work_keys_str_mv | AT chenshuying efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT shenqingyu efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT tangyamei efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT helei efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT liyi efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT lihui efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT limei efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials AT pengying efficacyandsafetyofaddingclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatientsametaanalysisofrandomizedcontrolledtrials |